PA(7)

product on market Capsule High Performance Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for PA(7)
Open Full PDF View on NIH DSLD →
Details

Label Data

5 Capsule(s)
Serving Size
24
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Mediator
1500 mg
1000 mg
Market median: 17.4mg (161 products)
AstraGin
100 mg

Other Ingredients

Hypromellose Microcrystalline Cellulose Silica Vegetable Stearate Calcium Silicate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: For clinical dosage: Take 5 capsules 30 minutes to 1 hour before workout or training session. Usage of PA(7) should be cycled in a pattern of 6 days on and 1 day off. Choose a consistent day of the week for your day off. For light to moderate training: Take 3 capsules per day immediately upon waking or 30 mins to 1 hour before exercise. Usage of PA(7) should be cycled as listed about.

Warnings & Precautions

Allergen information: Contains soy from soy lecithin

Formulation Notes

3 Clinically proven benefits Performance Larger improvements in strength Power Increased lean muscle gain Results Greater body recompositioning with a controlled diet

Made in the USA

Safe for sport

A sample of the batch from which this product was created was analyzed for substances banned by sport. No substances were found above the detection limits. Please see details at www.bscg.org.

mTOR elevation + nutrient partitioning

Vegan friendly

Additional Information

Questions, comments, or concerns? 1-800-971-4318

NSF Certified for Sport nsfsport.org BSCG Banned Substances Control Group The Gold Standard www.BSCG.org Certified drug free

HPN makes no compromises in producing the world's highest quality supplements.

Metadata

Product Details

UPC / SKU6 02573 10650 1
DSLD Entry Date2022-07-21
Product TypeOther Combinations
FormCapsule
DSLD ID271177
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
45
Avg Quality
7
Clinical Trial
1
Meta Analysis
B Effects of Whey Protein, Leucine, and Vitamin D Supplementation in Patients with Sarcopenia: A Systematic Review and Meta-Analysis
Meta Analysis Nutrients 2023 PubMed DOI
C Leucine-enriched Branched-chain Amino Acid on Muscle Thickness, Interleukin-6, SOFA Score in Critical Illness
Clinical Trial ClinicalTrials.gov 2023
C The Effects of Leucine Metabolites in Performance, Body Composition and Biochemical Markers of Muscle Damage
Clinical Trial ClinicalTrials.gov 2017
C Can Supplemental Leucine Offset Disuse-induced Muscle Atrophy?
Clinical Trial ClinicalTrials.gov 2017
C Leucine Supplementation in Sarcopenic Older Individuals
Clinical Trial ClinicalTrials.gov 2019
C The Effect of Leucine on Carnitine Transport to Skeletal Muscle
Clinical Trial ClinicalTrials.gov 2016
C Hydrolyzed Casein and Whey Protein Supplementation and the Addition of Leucine to Induce Protein Anabolism in Malnourished COPD Patients
Clinical Trial ClinicalTrials.gov 2009
C Resistance Exercise Training and Amino Acid Leucine Supplementation in Frail Elderly Women
Clinical Trial ClinicalTrials.gov 2013
View all evidence for Leucine →
Compare

Similar Products

View all Leucine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.